A case-control auditory evaluation of patients treated with artemether-lumefantrine

American Journal of Tropical Medicine and Hygiene

Volumn 74, Issue 2, 2006, Pages 211-214

  Hutagalung, Robert ^a   Htoo, Hsar ^a   Nwee, Paw ^a   Arunkamomkiri, Jaruwan ^a   Zwang, Julien ^a   Carrara, Verena I ^a   Ashley, Elizabeth ^a,b   Singhasivanon, Pratap ^c   White, Nicholas J ^b,c   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ARTEMETHER PLUS BENFLUMETOL; BENZODIAZEPINE; CHLOROQUINE; LOOP DIURETIC AGENT; MEFLOQUINE; QUININE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADOLESCENT; ADULT; AIR CONDUCTION; ARTICLE; AUDIOMETRY; AUDITORY ORIENTATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EXPOSURE; DRUG SAFETY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; FOOD DRUG INTERACTION; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; SCHOOL CHILD; TYMPANOMETRY; ACOUSTIC IMPEDANCE; AGED; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHILD; DRUG COMBINATION; EVALUATION; MIDDLE AGED; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS; RATTUS;

ACOUSTIC IMPEDANCE TESTS; ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; AUDIOMETRY; CASE-CONTROL STUDIES; CHILD; DRUG THERAPY, COMBINATION; ETHANOLAMINES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FLUORENES; HEARING LOSS; HUMANS; MALARIA; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33645798628     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.74.211     Document Type: Article

References (15)

1. White NJ, van Vugt M, Ezzet F, 1999. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 37: 105-125.
2. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F, 2000. Artemether- lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 94: 545-548.
3. Nontprasert A, Pukrittayakamee S, Dondorp AM, Clemens R, Looareesuwan S, White NJ, 2002. Neuropathologic toxicity of artemisinin derivatives in a mouse model. Am J Trop Med Hyg 67: 423-429.
4. Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG, 1994. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 (Suppl 1): S33-S36.
5. Petras JM, Kyle DE, Gettayacamin M, Young GD, Bauman RA, Webster HK, Corcoran KD, Peggins JO, Vane MA, Brewer TG, 1997. Arteether: risks of two-week administration in Macaca mulatta. Am J Trop Med Hyg 56: 390-396.
6. Hien TT, Turner GD, Mai NT, Phu NH, Bethell D, Blakemore WF, Cavanagh JB, Dayan A, Medana I, Weller RO, Day NP, White NJ, 2003. Neuropathological assessment of artemether-treated severe malaria. Lancet 362: 295-296.
7. Kissinger E, Hien TT, Hung NT, Nam ND, Tuyen NL, Dinh BV, Mann C, Phu NH, Loc PP, Simpson JA, White NJ, Farrar JJ, 2000. Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. Am J Trop Med Hyg 63: 48-55.
8. van Vugt M, Angus BJ, Price RN, Mann C, Simpson JA, Poletto C, Htoo SE, Looareesuwan S, White NJ, Nosten F, 2000. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg 62: 65-69.
9. Toovey S, Jamieson A, 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98: 261-267 (discussion 268-269].
10. Toovey S, 2005. Effects of weight, age, and time on artemether- lumefantrine associated ototoxicity and evidence of irreversibility. Travel Med Infect Dis (in press).
11. Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M, 1996. Drug-induced tinnitus and other hearing disorders. Drug Saf 14: 198-212.
12. Jacobson JT, Novotny GM, Elliott S, 1980. Clinical considerations in the interpretation of auditory brainstem response audiometry. J Otolaryngol 9: 493-504.
13. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ, 2000. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 44: 697-704.
14. Church MW, Blakley BW, Burgio DL, Gupta AK, 2004. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol 5: 227-237.
15. Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F, 1999. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 60: 547-555.